Pfizer Names New CEO

January 2011
Pharmaceutical Representative;Jan2011, Vol. 41 Issue 1, p8
The article announces the appointment of Ian C. Read as president, chief executive officer (CEO), and director of Pfizer Inc.


Related Articles

  • Between the lines, Read gives Pfizer split preview. Arnold, Matthew // Medical Marketing & Media;May2013, Vol. 48 Issue 5, p10 

    The article reports on Pfizer Inc. chief executive officer (CEO) Ian Read's statement over the innovative core and value company sides of the firm.

  • Pfizer CEO Read Received 44% Pay Increase with Promotion.  // MondayMorning;3/19/2012, Vol. 20 Issue 12, p1 

    The article announces that Ian Read, chief executive officer at Pfizer Inc., has been promoted as the president of the firm.

  • Pfizer Inc. (New York) may consider dividing its branded medicines and generic products units into separate businesses, CEO Ian Read said.  // MondayMorning;2/ 4/2013, Vol. 21 Issue 4, p1 

    The article focuses on Ian Read, chief executive officer (CEO) at New York State-based pharmaceutical firm Pfizer Inc. who states that the company is planning to separate its business related to branded medicines and generic products into individual entities. It mentions that company's plan to...

  • 04/08 (8) Pfizer to Keep Its $3.2 Billion-a-Year Consumer Health Business.  // MondayMorning;4/8/2013, Vol. 21 Issue 13, p8 

    The article reports that drugmaker U.S. Pfizer Inc. will not sell its consumer health business. It states that the company has been reducing in size since Ian Read became its chief executive officer (CEO). Read mentions that the consumer health business will remain with Pfizer as the business...

  • Pfizer Hosts Annual Meeting of Shareholders.  // Biomedical Market Newsletter;5/28/2011, p168 

    The article reports on the results of the shareholder's annual meeting of Pfizer Inc. It states that the board of directors announced that a 20-cent dividend on the company's stock for the second quarter of 2011 will be given to shareholders of record on May 13, 2011. According to Ian Read,...

  • Pfizer to buy Allergan for $160 billion. FALLOR, EVAN // Westchester County Business Journal;11/30/2015, Vol. 51 Issue 48, p10 

    The article reports on the announcement of pharmaceutical company Pfizer Inc. regarding an agreement to purchase pharmaceutical company Allergan PLC. Chief executive officer (CEO) and chairman Ian Read of Pfizer mentions the greater flexibility of the company to facilitate medical discovery and...

  • CORPORATE.  // MondayMorning;7/11/2011, Vol. 19 Issue 25, p2 

    The article reports that Pfizer Inc. changed its plans to sell its businesses stating that it would divest only the Animal Health and Baby Food units, with combined annual sales of 5.5 billion dollars. As stated, investors of the company have been pressing chief executive officer (CEO) Ian Read...

  • Pfizer Provides Update On Animal Health Strategic Alternatives Review Process.  // Biomedical Market Newsletter;6/7/2012, Vol. 21, p1 

    The article reports on an announcement made by Pfizer Inc. related to the steps in the strategic review process for the Animal Health business of the company. It informs that animal health will be taken as continuing operation for Pfizer's financial reporting purposes. As per Ian Read, chief...

  • AstraZeneca Dives After Rejection Of Pfizer's 'Final' Bid. AMY REEVES // Investors Business Daily;5/20/2014, pA01 

    AstraZeneca on Monday rejected Pfizer's "final proposal" buyout offer of $117 billion. Shares of the British drug giant dived as investors seemed to lose hope that the merger of titans would ever take place.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics